Hong Wu
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 32
- Liver Disease and Transplantation 29
- Cancer Research top 2%
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 15
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 31
- Organ Transplantation Techniques and Outcomes 29
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 19
-
- Gallbladder and Bile Duct Disorders 16
-
- Organ Donation and Transplantation 8
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hong Wu
128 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Hepatology 1.3k
- Cancer Research 662
- Epidemiology 894
- Surgery 1.0k
- Oncology 603
Countries citing papers authored by Hong Wu
This map shows the geographic impact of Hong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Wu more than expected).
Fields of papers citing papers by Hong Wu
This network shows the impact of papers produced by Hong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Wu. The network helps show where Hong Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironmentbreakdown → | 2025 | 24 |
| 3 | 2025 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 5 | |
| 7 | 2019 | 2 | |
| 8 | 2019 | 0 | |
| 9 | 2019 | 9 | |
| 10 | Contrast enhanced intraoperative ultrasonography-guided radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy through percutaneous or open approach: a retrospective cohort study | 2018 | 1 |
| 11 | 2016 | 0 | |
| 12 | [Value of focused critical ultrasound in the treatment of critical patients in Lushan earthquake]. | 2014 | 2 |
| 13 | 2014 | 8 | |
| 14 | 2014 | 38 | |
| 15 | 2014 | 23 | |
| 16 | 2012 | 19 | |
| 17 | 2011 | 7 | |
| 18 | 2011 | 27 | |
| 19 | A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteriabreakdown → | 2010 | 610 |
| 20 | 2009 | 14 |
About Hong Wu
Hong Wu is a scholar working on Hepatology, Transplantation and Surgery, having authored 135 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (31 papers), Liver Disease and Transplantation (29 papers), Organ Transplantation Techniques and Outcomes (29 papers), Pancreatic and Hepatic Oncology Research (19 papers), Gallbladder and Bile Duct Disorders (16 papers), Liver Disease Diagnosis and Treatment (15 papers) and Organ Donation and Transplantation (8 papers). The work is most often cited by research in Hepatology (1.3k citations), Cancer Research (662 citations) and Epidemiology (894 citations). Hong Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yong Zeng, Jiwei Huang, Lvnan Yan, Yinglong Xu, Liang Du, Zheyu Cheng, Jinzhou Wang, Kunlin Xie, Kefei Yuan and Mingheng Liao. Their work appears in journals such as Nature Communications, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.